Tuesday, 26 February 2019

Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

from NDTV Gadgets - Latest https://ift.tt/2XjoJ5n

No comments:

Post a Comment

RBI Governor: 'Rates may remain low in near to medium term'

"It is quite possible that the rates will remain low in the near to medium term, but that will depend on how conditions evolve," s...